Gene multiplications or point mutations in alpha (α)-synuclein are associated with familial and sporadic Parkinson's disease (PD). An increase in copper (Cu) levels has been reported in the cerebrospinal fluid and blood of PD patients, while occupational exposure to Cu has been suggested to augment the risk to develop PD. We aimed to elucidate the mechanisms by which α-synuclein and Cu regulate dopaminergic cell death. Short-term overexpression of wild type (WT) or mutant A53T α-synuclein had no toxic effect in human dopaminergic cells and primary midbrain cultures, but it exerted a synergistic effect on Cu-induced cell death. Cell death induced by Cu was potentiated by overexpression of the Cu transporter protein 1 (Ctr1) and depletion of intracellular glutathione (GSH) indicating that the toxic effects of Cu are linked to alterations in its intracellular homeostasis. Using the redox sensor roGFP, we demonstrated that Cu-induced oxidative stress was primarily localized in the cytosol and not in the mitochondria. However, α-synuclein overexpression had no effect on Cu-induced oxidative stress. WT or A53T α-synuclein overexpression exacerbated Cu toxicity in dopaminergic and yeast cells in the absence of α-synuclein aggregation. Cu increased autophagic flux and protein ubiquitination. Impairment of autophagy by overexpression of a dominant negative Atg5 form or inhibition of the ubiquitin/proteasome system (UPS) with MG132 enhanced Cu-induced cell death. However, only inhibition of the UPS stimulated the synergistic toxic effects of Cu and α-synuclein overexpression. Our results demonstrate that α-synuclein stimulates Cu toxicity in dopaminergic cells independent from its aggregation via modulation of protein degradation pathways.
Introduction
The progressive neurodegeneration in Parkinson's disease (PD) is characterized by the loss of dopaminergic neurons in the substantia nigra, and the presence of the fibrillar cytoplasmic aggregates of α-synuclein. Multiplication and mutations in α-synuclein (SNCA/ PARK1) (Chartier-Harlin et al., 2004; Polymeropoulos et al., 1997) as well as its abnormal aggregation are implicated in the etiology of familial or sporadic PD, as well as in other α-synucleinopathies (Galvin et al., 2001; Stefanis, 2012) . Ala53 to Thr is the most frequent mutation with a penetrance of 85%, while duplications have only reduced penetrance suggesting that additional factors might contribute to disease progression. Gene dosage (number of SNCA copies) has been associated with an earlier onset, more severe phenotype, and faster disease progression (Klein and Westenberger, 2012; Rochet et al., 2012) . Conformational changes in α-synuclein including oligomerization and fibrillogenesis are also associated with PD. α-synuclein aggregation is modulated by various mechanisms including phosphorylation, C-terminal truncation, interactions with metals or redox reactions (Breydo et al., 2012; Stefanis, 2012) . However, the pathogenicity of these conformational changes is unclear as some studies suggest that mature fibrils might 
